Trial Profile
A Randomized Trial Comparing Insulin Lispro Protamine Suspension With Insulin Glargine in Subjects With Type 2 Diabetes on Oral Antihyperglycemic Medications and Exenatide.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Insulin neutral protamine lispro (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jun 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met.
- 25 Jun 2010 Results presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA 2010).